Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared a post on LinkedIn:
“Sometimes the evidence just isn’t there.
I recently consulted on a young adult with Crigler-Najjar syndrome type 1 in acute crisis — bilirubin over 30, altered mental status, concern for acute-on-chronic kernicterus.
The team needed TPE. I needed a protocol.
Except there isn’t one.
Every case report I found treats plasmapheresis as a footnote.
No volumes.
No replacement fluid recommendations.
No schedule.
Nothing standardized.
So I made decisions based on pathophysiology, first principles, and the closest analogous literature I could find.
I wrote it all up – the case, the evidence gaps, and the reasoning – in a new blog post.
This is my ask to the apheresis and transfusion medicine community: if you’ve done TPE for Crigler-Najjar, share your experience.
We need to start building the evidence base, even if it begins with a conversation on LinkedIn.”
Other posts featuring Caitlin Raymond on Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda